Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 62756-091

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 62756-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-medroxy-fig1 (Spl Medroxy Fig1)

A logarithmic scale chart titled 'Risk estimates for breast cancer in DMPA users' showing odds ratios with 95% confidence intervals from various studies. The chart displays comparative risk estimates for breast cancer associated with DMPA use, with odds ratios ranging from about 0.6 to 7.4 indicated horizontally. Individual study results from Lee et al., Paul et al., WHO, Shapiro et al., and Li et al. (subdivided by all subjects and long-term DMPA use) are shown as square markers with horizontal error bars representing confidence intervals.*

FDA Label Image

Spl-medroxy-pfs-carton (Spl Medroxy Pfs Carton)

Carton label for Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/mL, in a 1 mL prefilled syringe. The product is for intramuscular use only, single-dose syringe, labeled by Sun Pharmaceutical Industries, Inc. Instructions for syringe preparation and needle activation, storage conditions, and manufacturer details are included on the label.*

FDA Label Image

Spl-medroxy-pfs-label (Spl Medroxy Pfs Label)

Label for Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/mL in a 1 mL single-dose syringe for intramuscular use. The label includes dosing instructions to shake vigorously before use and lists Sun Pharmaceutical Industries, Inc. as the manufacturer and distributor.*

FDA Label Image

Spl-medroxy-pil (Spl Medroxy Pil)

An illustration showing a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, with pregnancy rates from fewer than 1 to 85 or more pregnancies per 100 women per year. It categorizes birth control methods into four groups based on effectiveness: implants, injections, intrauterine devices, and sterilization at the top; birth control pills, skin patch, vaginal ring with hormones in the next group; condoms and diaphragm below that; then behavioral methods including no sex during fertile days, spermicide, and withdrawal; and finally, no birth control at the bottom with highest pregnancy rates.*

FDA Label Image

Spl-medroxy-structure (Spl Medroxy Structure)

Chemical structure of Medroxyprogesterone Acetate, a synthetic progestin compound represented by a fused four-ring steroid nucleus with attached functional groups including acetyl and carbonyl moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.